Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels

Hellström-Lindahl, E., Ravid, R., Nordberg, A.·2008·Neurobiology of Aging

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2006.10.010

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 52

  1. Apelt, 2003, Aging-related down-regulation of neprilysin, a putative b-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by astroglial upregulation in the vicinity of b-amyloid plaques, Neurosci. Lett., 339, 183, 10.1016/S0304-3940(03)00030-2 · DOI · Paper page
  2. Akiyama, 2001, Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition, Brain Res., 902, 277, 10.1016/S0006-8993(01)02390-3 · DOI
  3. Carpentier, 2002, Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy, J. Neuropathol. Exp. Neurol., 6, 849, 10.1093/jnen/61.10.849 · DOI
  4. Carson, 2001, Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?, J. Neurochem., 81, 1, 10.1046/j.1471-4159.2002.00855.x · DOI · Paper page
  5. Cleary, 2005, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat. Neurosci., 8, 79, 10.1038/nn1372 · DOI · Paper page
  6. Eckman, 2005, Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention, Biochem. Soc. Trans., 33, 1101, 10.1042/BST0331101 · doi:10.1042/bst0331101 · Paper page
  7. Evin, 2002, Biogenesis and metabolism of Alzheimer's disease Aβ amyloid peptides, Peptides, 23, 1285, 10.1016/S0196-9781(02)00063-3 · DOI · Paper page
  8. Funato, 1998, Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease, Am. J. Pathol., 152, 1633
  9. Guan, 2002, Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease, Brain Res., 956, 358, 10.1016/S0006-8993(02)03571-0 · DOI
  10. Hama, 2001, Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons, J. Biochem. (Tokyo), 130, 721, 10.1093/oxfordjournals.jbchem.a003040 · DOI
  11. Hellström-Lindahl, 1997, Expression of nicotinic receptor subunits mRNAs in lymphocytes from normal and Alzheimer patients, Alzheimer's Res., 3, 29
  12. Hellström-Lindahl, 1999, Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain, Mol. Brain Res., 66, 94, 10.1016/S0169-328X(99)00030-3 · DOI · Paper page
  13. Hellström-Lindahl, 2004, Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice, Eur. J. Neurosci., 19, 2703, 10.1111/j.0953-816X.2004.03377.x · DOI
  14. Hellström-Lindahl, 2004, Reduced levels of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer's patients, Neurobiol. Disease, 15, 351, 10.1016/j.nbd.2003.11.024 · DOI
  15. Higuchi, 2005, Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions, Biochim. Biophys. Acta, 1751, 60, 10.1016/j.bbapap.2005.02.013 · DOI
  16. Huang, 2004, Estrogen regulates neprilysin activity in rat brain, Neurosci. Lett., 367, 85, 10.1016/j.neulet.2004.05.085 · DOI
  17. Ingelsson, 2004, Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain, Neurology, 62, 925, 10.1212/01.WNL.0000115115.98960.37 · DOI · Paper page
  18. Ishii, 1997, Aβ 1-40 but not Aβ 1-42 levels in cortex correlate with apolipoprotein E ɛ4 allele dosage in sporadic Alzheimer's disease, Brain Res., 748, 250, 10.1016/S0006-8993(96)01363-7 · DOI · Paper page
  19. Iwata, 2001, Metabolic regulation of brain Aβ by neprilysin, Science, 292, 1550, 10.1126/science.1059946 · DOI · Paper page
  20. Iwata, 2002, Region-specific reduction of Aβ degrading endopeptidase, neprilysin, in mouse hippocampus upon aging, J. Neurosci. Res., 70, 493, 10.1002/jnr.10390 · DOI · Paper page
  21. Iwata, 2004, Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain, J. Neurosci., 24, 991, 10.1523/JNEUROSCI.4792-03.2004 · DOI · Paper page
  22. Kanemitsu, 2003, Human neprilysin is capable of degrading amyloid b peptide not only in the monomeric form but also the pathological oligomeric form, Neurosci. Lett., 350, 113, 10.1016/S0304-3940(03)00898-X · DOI · Paper page
  23. Kar, 2004, Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer's disease, J. Psychiatry Neurosci., 29, 427
  24. Leissring, 2003, Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death, Neuron, 40, 1087, 10.1016/S0896-6273(03)00787-6 · DOI · Paper page
  25. Lue, 1999, Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X · DOI · Paper page
  26. Marr, 2004, Neprilysin regulates amyloid β peptide levels, J. Mol. Neurosci., 22, 5, 10.1385/JMN:22:1-2:5 · DOI
  27. Mc Khann, 1984, Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of department of health and human services task forces on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  28. Mohajeri, 2002, Aβ 42-induced increase in neprilyin is associated with prevention of amyloid plaque formation in vivo, J. Biol. Chem., 277, 35460, 10.1074/jbc.M202899200 · DOI
  29. Mohajeri, 2004, Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease, FEBS Lett., 562, 16, 10.1016/S0014-5793(04)00169-3 · DOI
  30. Mousavi, 2003, Protein and mRNA level of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease, Neuroscience, 122, 515, 10.1016/S0306-4522(03)00460-3 · DOI
  31. Hellström-Lindahl, 2002, Chronic nicotinic treatment reduces B-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPSWE), J. Neurochem., 81, 655, 10.1046/j.1471-4159.2002.00874.x · DOI · Paper page
  32. Pardossi-Piquard, 2005, Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of β APP and APLP, Neuron, 46, 541, 10.1016/j.neuron.2005.04.008 · DOI · Paper page
  33. Pardossi-Piquard, 2006, Neprilysin activity and expression are controlled by nicastrin, J. Neurochem., 97, 1052, 10.1111/j.1471-4159.2006.03822.x · DOI
  34. Parvathy, 2001, Correlation between Aβx-40-, Aβx-42-, and Aβx-43-containing amyloid plaques and cognitive decline, Arch. Neurol., 58, 2025, 10.1001/archneur.58.12.2025 · DOI
  35. Petanceska, 2000, Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain, Exp. Gerontol., 35, 1317, 10.1016/S0531-5565(00)00157-1 · DOI
  36. Piccini, 2005, β-Amyloid is different in normal aging and in Alzheimer's disease, J. Biol. Chem., 280, 34186, 10.1074/jbc.M501694200 · DOI · Paper page
  37. Price, 1999, Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease, Ann. Neurol., 45, 358, 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
  38. Qui, 1997, Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other non-neuronal cells, J. Biol. Chem., 272, 6641, 10.1074/jbc.272.10.6641 · DOI · Paper page
  39. Reisberg, 1982, The global deterioration scale for assessment of primary degenerative dementia, Am. J. Psychol., 139, 1136, 10.1176/ajp.139.9.1136 · DOI · Paper page
  40. Roques, 1993, Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacolgy, Pharmacol. Rev., 45, 87
  41. Russo, 2005, Neprilysin decreases uniformly in Alzheimer's disease and in normal aging, FEBS, 579, 6027, 10.1016/j.febslet.2005.09.054 · DOI
  42. Saito, 2005, Somatostatin regulates brain amylod B peptide Aβ 42 through modulation of proteolytic degradation, Nat. Med., 11, 434, 10.1038/nm1206 · DOI · Paper page
  43. Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
  44. Selkoe, 2003, Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics, Ann. Rev. Pharmacol. Toxicol., 43, 545, 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
  45. Turner, 2001, The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function, Bioessays, 23, 261, 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K · DOI · Paper page
  46. Vardy, 2005, Proteolytic mechanism in amyloid-β metabolism: therapeutic implications for Alzheimer's disease, Trends Mol. Med., 1, 462
  47. Walker, 2000, Apolipoprotein E4 promotes the early deposition of Aβ 42 and the Aβ40 in the elderly, Acta Neuropathol., 100, 36, 10.1007/s004010051190 · DOI
  48. Wang, 2003, Oxidized neprilysin in aging and Alzheimer's disease, Biochem. Biophys. Res. Commun., 310, 236, 10.1016/j.bbrc.2003.09.003 · DOI
  49. Wang, 2005, Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging, J. Neuropathol. Exp. Neurol., 64, 378, 10.1093/jnen/64.5.378 · DOI
  50. Yasojima, 2001, Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide, Neurosci. Lett., 297, 97, 10.1016/S0304-3940(00)01675-X · DOI · Paper page
  51. Yasojima, 2001, Relationship between amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain, Brain Res., 919, 115, 10.1016/S0006-8993(01)03008-6 · DOI · Paper page
  52. Zhu, 2005, Oxidative imbalance in Alzheimer's disease, Mol. Neurobiol., 31, 205, 10.1385/MN:31:1-3:205 · DOI

Cited by

See all 165

Metadata

Authors
Hellström-Lindahl, E., Ravid, R., & Nordberg, A.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2008-02
Volume
29
Issue
2
Pages
210-221
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2073364218
Cited by
165
References
13
FWCI
5.10
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2006.10.010
The paper
Hellström-Lindahl, E., Ravid, R., & Nordberg, A. (2008). Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2006.10.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.